Medical and Pharmaceutical Pulmonx Corporation shares spike on record-breaking Q4 revenue Pulmonx achieved USD$83.8 million in worldwide revenue, reflecting a robust 22 per cent growth over 2023 Joseph MortonFebruary 21, 2025
Medical and Pharmaceutical Summit Therapeutics up 55% as lung cancer drug outperforms Merck’s Analysts have now given the company a much higher share target price too Rowan DunneSeptember 9, 2024
AI and Autonomy Is Artificial Intelligence actually the future: A Mugglehead roundup Softbank CEO predicts that AGI will be achieved by 2030 and be 10 times more powerful than human intelligence Joseph MortonJune 21, 2024